Page 2 - Celiac Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid...

SQI Diagnostics Announces New Corporate Website News provided by Share this article New Website Provides Essential Information on Company's Strategic Initiative TORONTO, Feb. 18, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSX-V: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today is proud to announce the launch of its newly redesigned website at https://www.sqidiagnostics.com. The revamped site features a streamlined, mode...

SQI Diagnostics Reports Fourth Quarter and Fiscal 2020 Results News provided by Share this article Share this article TORONTO, Jan. 27, 2021 /PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2020.  Q4 2020 Financial Highlights Sales were $0.3M, compared to $0.6M in Q4 2019 due to a combination of t...

Submission to U.S. FDA TORONTO, Jan. 25, 2021 /PRNewswire/ - SQI Diagnostics Inc.(the "Company" or "SQI") ( (TSXV: SQD); (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today announced that patient enrollment began for the Company's clinical study for its direct-to-consumer COVID-19 HOME Antibody Test with the data to be used to support its EUA regulatory submission to the U.S. FDA. The clinical study is being conducted in the United States and will ...

SQI Diagnostics Announces $4 Million Funding via Warrant Exercise by Insiders News provided by Share this article   TORONTO, Dec. 30, 2020 /PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today announced that 19,074,997 common share purchase warrants of the Company (the "Warrants") have been exercised by certain insiders, who are control persons of the Company, for aggregate gross proceeds of approximately...